NKX2-2 (NK2 homeobox 2)
2008-01-01 Stephen L Lessnick  , Leah A Owen   AffiliationDepartment of Oncological Sciences, University of Utah School of Medicine, Center for Children, Huntsman Cancer Institute,, Division of Pediatric Hematology\\\/Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA
Identity
HGNC
LOCATION
20p11.22
LOCUSID
ALIAS
NKX2.2,NKX2B
FUSION GENES
DNA/RNA
Description
Start- 21,439,648 base pairs from p arm terminus; End- 21,442,699 base pairs from p arm terminus; Size- 3,051 bases; Orientation- minus strand
Proteins

Schematic of NKX2-2 functional domains. The positions of the transcriptional repressor domain (TN), the homeodomain (HD), the NK2-specific domain (SD), and the transcriptional activation domain (TAD) are shown.
Description
273 amino acids; 30133 Da. NKX2-2 is a member of the NK2 family of homeobox transcription factors. It has known roles in the development of the CNS as well as pancreatic beta cell differentiation. In the CNS NKX2-2 is known to be activated by SHH signaling which is important for its initial role in ventral patterning. NKX2-2 expression has additionally been shown to be critical for the differentiation of oligodendrocytes, and in fact necessary for this process to occur. In both instances, NKX2-2 mediated transcripitional repression is both necessary and sufficient for these processes to occur. Regulation of NKX2-2 expression in the pancreas is less well understood. NKX2-2 knock-out mice die soon after birth from diabetic complications as a result of a lack of fully differentiated pancreatic beta cells. While NKX2-2 mediated transcriptional repression has been demonstrated to be necessary and sufficient for its role in ß-cell differentiation, it remains unclear whether NKX2-2 mediated transcriptional activation is important for NKX2-2 function in adult ß-cells.
Expression
V3 neural progenitors; oligodendrocyte precursor cells; precursor and adult pancreatic beta cells.
Localisation
Nuclear
Function
NKX2-2 is a transcription factor
Homology
NKX2-2 shares homology with other members of the NK2 family of transcription factors most notably in the TN transcriptional repression, DNA binding homeodomain, and specific domain regions.
Implicated in
Entity name
Ewings sarcoma
Prognosis
Roughly 50% survival at 5 years for Ewings sarcoma.
Cytogenetics
Ewings sarcoma cells harbor the characteristic translocation t(11;22)(q24;q12) in roughly 90% of cases.
Hybrid gene
Fusion protein
The translocation fusion product is termed EWS/FLI.

Schematic diagram of wild-type EWS, wild-type FLI, and the EWS/FLI fusion transcripts.
Oncogenesis
NKX2-2 is up-regulated in Ewings sarcoma by the EWS/FLI translocation protein product. NKX2.2 expression is necessary for the oncogenic phenotype of Ewings sarcoma cells.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 10217145 | 1999 | Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. | Briscoe J et al |
| 1522903 | 1992 | Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. | Delattre O et al |
| 17202186 | 2007 | Nkx2.2-repressor activity is sufficient to specify alpha-cells and a small number of beta-cells in the pancreatic islet. | Doyle MJ et al |
| 8516324 | 1993 | Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. | May WA et al |
| 11290324 | 2001 | Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fate in the ventral neural tube. | Muhr J et al |
| 16969112 | 2006 | Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. | Owen LA et al |
| 16697960 | 2006 | Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. | Smith R et al |
| 9584121 | 1998 | Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. | Sussel L et al |
| 10944215 | 2000 | Intramolecular control of transcriptional activity by the NK2-specific domain in NK-2 homeodomain proteins. | Watada H et al |
| 15695521 | 2005 | Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor. | Wei Q et al |
Other Information
Locus ID:
NCBI: 4821
MIM: 604612
HGNC: 7835
Ensembl: ENSG00000125820
Variants:
dbSNP: 4821
ClinVar: 4821
TCGA: ENSG00000125820
COSMIC: NKX2-2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000125820 | ENST00000377142 | O95096 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37821536 | 2024 | A novel stop-loss mutation in NKX2-2 gene as a cause of neonatal diabetes mellitus: molecular characterization and structural analysis. | 0 |
| 37821536 | 2024 | A novel stop-loss mutation in NKX2-2 gene as a cause of neonatal diabetes mellitus: molecular characterization and structural analysis. | 0 |
| 34985580 | 2022 | Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance? | 2 |
| 34985580 | 2022 | Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance? | 2 |
| 32065490 | 2020 | Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells. | 4 |
| 32716131 | 2020 | Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids. | 4 |
| 32065490 | 2020 | Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells. | 4 |
| 32716131 | 2020 | Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids. | 4 |
| 28800015 | 2019 | The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma. | 3 |
| 30683671 | 2019 | Insight into the Etiology of Undifferentiated Soft Tissue Sarcomas from a Novel Mouse Model. | 6 |
| 28800015 | 2019 | The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma. | 3 |
| 30683671 | 2019 | Insight into the Etiology of Undifferentiated Soft Tissue Sarcomas from a Novel Mouse Model. | 6 |
| 28616785 | 2018 | Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors. | 15 |
| 30376220 | 2018 | NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls. | 15 |
| 28616785 | 2018 | Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors. | 15 |
Citation
Stephen L Lessnick ; Leah A Owen
NKX2-2 (NK2 homeobox 2)
Atlas Genet Cytogenet Oncol Haematol. 2008-01-01
Online version: http://atlasgeneticsoncology.org/gene/44177/nkx2-2
